Jump to content

Risk of fracture in men with prostate cancer on androgen deprivation therapy


Paul Edwards

Recommended Posts

From the lack of information given, one must assume that ADT would be used for those with a raised PSA which would include metastatic disease as a possible cause, 

ADT will risk osteoporosis. Prostate cancer in bones can result in bone weakness.

Both of these will risk increase risk of fracture.

Hence, I am not surprised about the "risk of fracture in men with prostate cancer on androgen deprivation therapy".

Bruce Kynaston.

Link to comment
Share on other sites

Archived

This topic is now archived and is closed to further replies.

×
×
  • Create New...